Jaisim Shah's Net Worth
$743 Thousand
Who is Jaisim Shah?
Jaisim Shah does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sorrento Therapeutics, Inc., CYTRX CORP, PROTEIN DESIGN LABS INC/DE, Scilex Holding Co, and FACET BIOTECH CORP.
SEC CIK
Jaisim Shah's CIK is 0001242133
Past Insider Trading and Trends
2007 was Jaisim Shah's most active year for acquiring shares with 15 total transactions. Jaisim Shah's most active month to acquire stocks was the month of March. 2007 was Jaisim Shah's most active year for disposing of shares, totalling 28 transactions. Jaisim Shah's most active month to dispose stocks was the month of March. 2015 saw Jaisim Shah paying a total of $312,673.50 for 132,189 shares, this is the most they've acquired in one year. In 2007 Jaisim Shah cashed out on 103,040 shares for a total of $1,274,280.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +9.75% | 10K |
$1.79 | $17,903.58 | 112.63K |
Jun 15
| |||
Form 4
| +10.80% | 10K |
$5.15 | $51,500.00 | 102.63K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
| +41.55% | 27.19K |
$11.50 | $312,673.50 | 92.63K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
| +1.55% | 1K |
$8.65 | $8,650.00 | 65.44K |
Nov 25
| |||
Form 4
| +1.58% | 1K |
$9.00 | $9,000.00 | 64.44K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTRX CORP (LADX) Snapshot price: $1.5
Sr. VP - Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROTEIN DESIGN LABS INC/DE No price found
SVP, Mktg & Bus. Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.41% | 1.25K |
$8.54 | $10,681.74 | 16.13K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
$20.68 | -$175,149.68 | 13.94K |
Scheduled
|
Apr 30
| ||
Form 4
|
—
|
0
|
$19.66 | -$160,178.45 | 13.94K |
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
$16.18 | -$293,828.23 | 13.94K |
Scheduled
|
Apr 11 - Apr 13
| ||
Form 4
| +868.06% | 12.5K |
—
|
—
| 13.94K |
Jul 20
| |||
Form 4
|
—
|
0
|
$21.65 | -$93,550.00 | 1K |
Scheduled
|
Jan 9
| ||
Form 4
| -52.34% | -829.00 |
$19.39 | -$248,461.90 | 755 |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
$19.65 | -$73,550.00 | 829 |
Scheduled
|
Apr 26
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
$18.65 | -$61,008.00 | 829 |
Mar 5
| |||
Form 4/A
|
—
|
0
|
$18.66 | -$2,547.00 | 829 |
Feb 26
| |||
Form 4
|
—
|
0
|
$18.66 | -$3,822.99 | 829 |
Feb 26
| |||
Form 4
|
—
|
0
|
$17.65 | -$53,550.00 | 829 |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scilex Holding Co (SCLX) Snapshot price: $1.05
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.38% | 32K |
$0.99 | $31,670.40 | 109.33K |
Oct 29
| |||
Form 4
| +63.38% | 30K |
$0.99 | $29,751.00 | 77.33K |
Oct 16
| |||
Form 4
| +42.00% | 14K |
$1.73 | $24,220.00 | 47.33K |
Jun 20
| |||
Form 4
|
∞
| 33.33K |
$1.41 | $46,999.53 | 33.33K |
Jun 14
| |||
Form 4
| +881.50% | 140K |
$0.87 | $121,945.18 | 155.88K |
May 16 - May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
SVP, Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||